Go Back

Morepen Laboratories Limited. This is to inform you that pursuant to the fresh issue of equity sh...

Posted: 01 Jul 2025

Morepen Laboratories Limited. This is to inform you that pursuant to the fresh issue of equity shares by Morepen Medipath Limited (formerly known as Morepen Medtech Limited) ("MML"), a subsidiary, the company received an offer to subscribe to the equity shares. The Finance Committee of the Board of Directors of the company at its meeting held today, June 30, 2025, has, inter alia, approved the subscription of 2,00,000 (Two Lakh) equity shares under the aforesaid issue. As a result of this transaction, the company�s shareholding in MML has been reduced from 80% to 60%. The details, as required under the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given under as Annexure. Sr. No. Particulars Details 1. Details and reasons for restructuring; Issue and allotment of fresh equity shares by Morepen Medipath Limited (formerly known as Morepen Medtech Limited) ("MML"), a subsidiary company, recently incorporated for carrying out the home health business. 2. Quantitative and/ or qualitative effect of restructuring; The company has subscribed 2,00,000 (Two Lakh) equity shares, under the rights issue 3. Details of benefit, if any, to the promoter/promoter group/group companies from such proposed restructuring; Pursuant to above, the shareholding of the company�s promoter group in Morepen Medipath Limited, has been increased from 20% to 40%. 4. Brief details of change in shareholding pattern (if any) of all entities. The shareholding of the Company in MML, changes as follows: Pre-Transaction Post-Transaction Name of the shareholder Number of Shares % of total paid-up share capital Number of Shares % of total paid-up share capital Morepen Laboratories Limited 8,80,000 80% 10,80,000 60% Persons belonging to promoters & promoter group of MLL and relatives thereof. 2,20,000 20% 7,20,000 40% Total 11,00,000 100% 18,00,000 100%